Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

R&D

- PMLiVE

A quest for innovative solutions

UCB looks to the future through a PRISM

- PMLiVE

Dr Sotirios Stergiopoulos leaves Shire for Ipsen

He becomes the French biopharma’s chief medical officer

- PMLiVE

Richard Paulson joins Ipsen as CEO for North America

He also becomes an executive vice-president at the French biopharma

- PMLiVE

Ipsen appoints Aidan Murphy as EVP, technical operations

He is promoted from senior VP biologics development and manufacturing

- PMLiVE

Accelerating innovation

Ipsen’s Alexandre Lebeaut on the French firm’s oncology plans, global focus and R&D approach

- PMLiVE

Pharma is ‘getting lower returns on R&D’

And Deloitte says the number of drugs in late-stage trials tumbled by 16%

- PMLiVE

Ipsen promotes Alexis Vandier as general manager, France

He will also join the French biopharma group’s global speciality leadership team

- PMLiVE

Pulling together

Making sense of the present and future environment for the life science sector in the UK

- PMLiVE

Gene therapy

When will it deliver?

- PMLiVE

Pushing the accelerator

How eClinical technologies can speed  up the drug development process

Roche Basel Switzerland

Roche biggest pharma R&D spender in PwC survey

Pharma giant on track to spend 21.9% of its total revenue on research this year

- PMLiVE

Ipsen’s liver cancer treatment clears phase III trial

Cabometyx on track for new liver cancer indication

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links